Light and Laser Therapies Offer New Hope for Stubborn Acne Cases
A clinical review explores how light and laser devices can control acne when standard medications fall short or cause side effects.
Summary
Acne vulgaris is typically managed with topical and systemic medications, but many patients experience flares, side effects, or wish to avoid drugs altogether. This clinical review published in the Journal of the American Academy of Dermatology examines the growing role of light and laser-based therapies as adjuncts or alternatives. Technologies reviewed include visible light therapy, photodynamic therapy, photopneumatic therapy, intense pulsed light, pulsed dye laser, potassium titanyl phosphate lasers, infrared lasers, and the emerging 1726 nm fiber-coupled diode laser. The authors highlight these modalities for their efficacy and durable outcomes, positioning them as valuable tools in a comprehensive, individualized acne management strategy.
Detailed Summary
Acne vulgaris remains one of the most prevalent skin conditions globally, affecting quality of life across all age groups. While the gold standard of care involves a stepwise combination of topical and systemic medications, a significant subset of patients continues to struggle with inadequate control, recurrent flares, or intolerable side effects from conventional treatments.
This 2025 clinical review in the Journal of the American Academy of Dermatology systematically examines the landscape of light and laser-based therapies for acne. The authors cover a broad spectrum of modalities: visible light therapy, photodynamic therapy (PDT), photopneumatic therapy, intense pulsed light (IPL), pulsed dye laser (PDL), potassium titanyl phosphate (KTP) lasers, infrared lasers, and the novel 1726 nm fiber-coupled diode laser.
Each modality targets acne through distinct mechanisms — from destroying Cutibacterium acnes bacteria via light activation to selectively ablating sebaceous glands. The 1726 nm diode laser is highlighted as a particularly promising innovation, with early evidence suggesting targeted sebaceous gland destruction with favorable safety profiles.
The clinical implications are meaningful: dermatologists now have a growing toolkit to personalize acne treatment, especially for patients who cannot tolerate isotretinoin or long-term antibiotics. These devices may also reduce antibiotic resistance concerns associated with prolonged systemic therapy.
Caveats include the review's reliance on existing literature without new primary data, variability in study quality across modalities, and the higher cost and limited accessibility of laser-based treatments. Standardization of treatment protocols remains an ongoing challenge in the field.
Key Findings
- Light and laser therapies are effective adjuncts when topical or systemic acne medications fail or cause side effects.
- The novel 1726 nm fiber-coupled diode laser shows promise for targeted sebaceous gland destruction.
- Photodynamic therapy and intense pulsed light offer durable acne control through distinct antimicrobial and anti-inflammatory mechanisms.
- These modalities may help reduce reliance on systemic antibiotics, addressing antibiotic resistance concerns.
- A personalized, combination approach integrating devices with medications is emerging as optimal acne management.
Methodology
This is a narrative clinical review published in a peer-reviewed dermatology journal. It synthesizes existing literature on multiple light and laser modalities rather than presenting new primary data. No meta-analysis or systematic review methodology is described.
Study Limitations
The review is based solely on existing literature, meaning conclusions are limited by the quality and heterogeneity of prior studies. No new clinical trial data are presented, and treatment protocols across modalities lack standardization. Cost and access barriers may limit real-world applicability of these technologies.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.